REFERENCES
Bleakman, D. and Lodge, D., Neuropharmacology, 1998, vol. 37, no.10/11, pp. 1187–1204.
Tolle, T.R., Berthele, A., Zieglgansberger, W., et al., J. Neurosci., 1993, vol. 13, no.12, pp. 5009–5028.
Hoo, K., Legutko, B., Rizkalla, G., et al., Neuropharmacology, 1999, vol. 38, no.12, pp. 1811–1817.
Gu, Z.Q., Hesson, D.P., Pelletier, J.C., et al., J. Med. Chem., 1995, vol. 38, no.14, pp. 2518–2520.
Armstrong, N. and Gouaux, E., Neuron, 2000, vol. 28, no.1, pp. 165–181.
Insight II Modeling Environment, San Diego: Molecular Simulations.
Henikoff, S. and Henikoff, J.G., Proc. Natl. Acad. Sci. USA, 1992, vol. 89, no.22, pp. 10915–10919.
Garnier, J., Gibrat, J.F., and Robson, B., Meth. Enzymol., 1996, vol. 266, pp. 540–553.
Bairoch, A. and Apweiler, R., Nucl. Acids Res., 2000, vol. 28, no.1, pp. 45–48.
Paas, Y., Eisenstein, M., Medevielle, F., et al., Neuron, 1996, vol. 17, no.5, pp. 979–990.
Sali, A. and Blundell, T.L., J. Mol. Biol., 1990, vol. 212, no.2, pp. 403–428.
Baskin, I.I., Belenikin, M.S., Ekimova, E.V., et al., Dokl. Akad. Nauk, 2000, vol. 374, no.3, pp. 347–351.
Sybyl 6.7.2. Tripos, Inc. 1699 South Hanley Road, St. Louis, MO 63144. http://www.tripos.com.
Kunishima, N., Shimada, Y., Tsuji, Y., et al., Nature, 2000, vol. 407, no.6807, pp. 971–977.
Pedregal, C., Collado, I., Escribano, A., et al., J. Med. Chem., 2000, vol. 43, no.10, pp. 1958–1968.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Belenikin, M.S., Baskin, I.I., Costantino, G. et al. Molecular Modeling of the Closed Forms of the Kainate-Binding Domains of Kainate Receptors and Qualitative Analysis of the Structure–Activity Relationships for Some Agonists. Doklady Biochemistry and Biophysics 386, 239–244 (2002). https://doi.org/10.1023/A:1020799209272
Issue Date:
DOI: https://doi.org/10.1023/A:1020799209272